Headquartered in Shenzhen, after years of steady operation and rapid development, the company has become an innovative and scientific research-oriented comprehensive pharmaceutical group. The company has always adhered to scientific and technological innovation as the strategic starting point, to create a high-barrier complex preparation technology platform as the strategic goal, has laid out four innovative high-barrier complex preparation R & D platform. It has two large listed companies, Health Yuan and Lizhu Pharmaceutical, more than 20 major holding subsidiaries, and currently employs 13000 people. By the end of 2021, the company had total assets of 31.104 billion yuan and operating income of 15.904 billion yuan. Mainly engaged in pharmaceutical products and health products research and development, production and sales. The company's business scope covers chemical preparations, traditional Chinese medicine preparations, chemical raw materials and intermediates, diagnostic reagents and equipment, health food and other fields. The company won the Honor of Humane Service Award, the top 20 most competitive pharmaceutical listed companies in China in the second session, the top 20 most competitive pharmaceutical listed companies in China, and the top 100 tax-paying enterprises in 2010.